메뉴 건너뛰기




Volumn 29, Issue 5, 2011, Pages 401-403

Mandating race: How the USPTO is forcing race into biotech patents

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; HEALTH CARE DISPARITY; LEGAL ASPECT; PATENT; PRIORITY JOURNAL; RACE; RACISM; REVIEW; UNITED STATES;

EID: 79955778823     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.1864     Document Type: Review
Times cited : (12)

References (20)
  • 3
    • 79955767607 scopus 로고    scopus 로고
    • UsC §112
    • UsC §112.
  • 7
    • 79955774239 scopus 로고    scopus 로고
    • Us patent application 20040126794
    • Bugawan, t. and erlich, H. Us patent application 20040126794 (2004).
    • (2004)
    • Bugawan, T.1    Erlich, H.2
  • 9
    • 79955764116 scopus 로고    scopus 로고
    • J. Us patent application no. 20020039733
    • Lenz, H.J. and stoehlmacher, J. Us patent application no. 20020039733 (2003).
    • (2003)
    • Lenz, H.J.1    Stoehlmacher2
  • 10
    • 79955753492 scopus 로고    scopus 로고
    • Ex parte 2010 WL 2505311 (Bd. pat. app. & Int.)
    • Ex parte Jennifer Jones McIntire, Rosemarie Dekruyff, Dale T. Umetsu, and Gordon Freeman. 2010 WL 2505311 (Bd. pat. app. & Int. 2010), 8.
    • (2010) , pp. 8
    • McIntire, J.J.1    Dekruyff, R.2    Umetsu, D.T.3    Freeman, G.4
  • 11
    • 79955768275 scopus 로고    scopus 로고
    • Us patent no. 6, 716, 581
    • Lenz, H.J. and stoehlmacher, J. Us patent no. 6,716,581 (2004).
    • (2004)
    • Lenz, H.J.1    Stoehlmacher, J.2
  • 12
    • 79955757640 scopus 로고    scopus 로고
    • Us patent application no. 20020039733
    • Lenz, H.J. and stoehlmacher, J. Us patent application no. 20020039733 (2003).
    • (2003)
    • Lenz, H.J.1    Stoehlmacher, J.2
  • 13
    • 79955776888 scopus 로고    scopus 로고
    • Us patent no. 6,716,581, p.a.I.R. Docket no. 13761-7001/app. Control no. 09/824,629.
    • Us patent no. 6,716,581, p.a.I.R. Docket no. 13761-7001/app. Control no. 09/824,629.
  • 14
    • 79955779703 scopus 로고    scopus 로고
    • [Final action] Office action Responsive to Communication Filed on september 16, 2002. november 20
    • Carla Myers. [Final action] Office action Responsive to Communication Filed on september 16, 2002. november 20, 2002, 3.
    • (2002) , pp. 3
    • Myers, C.1
  • 15
    • 79955747927 scopus 로고    scopus 로고
    • Us patent no. 6,716,581, p.a.I.R. Docket no. 13761-7001/app. Control no. 09/824,629
    • Us patent no. 6,716,581, p.a.I.R. Docket no. 13761-7001/app. Control no. 09/824,629.
  • 16
    • 79955750385 scopus 로고    scopus 로고
    • [Final action] Office action Responsive to Communication Filed on september 16, 2002. november 20
    • Carla Myers. [Final action] Office action Responsive to Communication Filed on september 16, 2002. november 20, 2002, 5.
    • (2002) , pp. 5
    • Myers, C.1
  • 17
    • 79955752261 scopus 로고    scopus 로고
    • See, E.g., Genentech, Inc. v. Novo Nordisk, A/S, 108 F.3d 1361 (Fed. Cir. 1997).
    • See, E.g., Genentech, Inc. v. Novo Nordisk, A/S, 108 F.3d 1361 (Fed. Cir. 1997).
  • 20
    • 79955763466 scopus 로고    scopus 로고
    • Us patent no. 6,716,581, p.a.I.R. Docket no. 13761-7001/app. Control no. 09/824,629. David Maher. amendment and Response Under 37 C.F.R. s. 1.111. september 16, 2002.
    • Us patent no. 6,716,581, p.a.I.R. Docket no. 13761-7001/app. Control no. 09/824,629. David Maher. amendment and Response Under 37 C.F.R. s. 1.111. september 16, 2002.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.